This study is testing different ways to treat high-risk head and neck cancer. This cancer starts in squamous cells, which are thin, flat cells. The usual treatment is radiation therapy with a chemotherapy drug called cisplatin. This study will try other treatments too: adding drugs like docetaxel, cetuximab, and atezolizumab. Cetuximab and atezolizumab are special medicines that help the body’s immune system fight cancer. The study will compare these treatments to see if they are better at stopping cancer from coming back.
- Length and Follow-up: The treatment lasts 6 weeks, with follow-ups for several years.
- Eligibility: You must have had surgery for head and neck cancer and meet specific health criteria.
- Risks: Possible side effects include those common to cancer treatments, like fatigue and nausea.
Participants will be checked with scans and blood tests during the study. It’s important to understand all the details and discuss them with your doctor before deciding if you want to join the study.
How understandable was the trial content above?
Hard to understand
Easy to understand